| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/17/2014 | US20140199728 Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture |
| 07/17/2014 | US20140199399 Use of tgf-beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia |
| 07/17/2014 | US20140199361 Inhibitory anti-factor xii/xiia monoclonal antibodies and their uses |
| 07/17/2014 | US20140199330 Protein involved in detection of cancer metastasis and a treatment thereof |
| 07/17/2014 | US20140199328 Interferon Alpha Antibodies And Their Uses |
| 07/17/2014 | US20140199326 Inhibitors of Cathepsin S for Prevention or Treatment of Obesity-Associated Disorders |
| 07/17/2014 | US20140199325 Novel polypeptides and use thereof |
| 07/17/2014 | US20140199323 Monoclonal Antibody |
| 07/17/2014 | US20140199321 Stabilizing polypeptides which have been exposed to urea |
| 07/17/2014 | US20140199320 Modulators of the nlrp3 inflammasome il-1beta pathway for the prevention and treatment of acne |
| 07/17/2014 | US20140199319 Methods for increasing the efficiency of hybridoma generation |
| 07/17/2014 | US20140199318 Agonistic autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in alzheimer's and vascular dementia |
| 07/17/2014 | US20140199317 Actriia binding agents and uses thereof |
| 07/17/2014 | US20140199316 Methods of treating complications and disorders associated with g-csf administration |
| 07/17/2014 | US20140199315 Sp35 Antibodies and Uses Thereof |
| 07/17/2014 | US20140199314 Methods and compositions for regulating iron homeostasis by modulation of bmp-6 |
| 07/17/2014 | US20140199313 Process for the Production of Fine Chemicals |
| 07/17/2014 | US20140199312 DDR1-Binding Agents and Methods of Use Thereof |
| 07/17/2014 | US20140199311 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 07/17/2014 | US20140199310 Compositions comprising agents that inhibit neuropilin and tolloid like 2 |
| 07/17/2014 | US20140199309 Fragment of secreted heat shock protein-90alpha (hsp90alpha) as vaccines or epitope for monoclonal antibody drugs or target for small molecule drugs against a range of solid human tumors |
| 07/17/2014 | US20140199307 Dosage regimen for administering a cd19xcd3 bispecific antibody to patients at risk for potential adverse effects |
| 07/17/2014 | US20140199306 Compositions and methods for antibodies targeting epo |
| 07/17/2014 | US20140199302 Compositions for regulating iron homeostasis and methods of using same |
| 07/17/2014 | US20140199301 Recombinant antibody structures binding to and blocking the activity of vascular endothelial growth factor 2 (vegfr- 2/kdr) |
| 07/17/2014 | US20140199295 Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains |
| 07/17/2014 | US20140199294 Heterodimerized polypeptide |
| 07/17/2014 | US20140199293 Humanized antibody compositions and methods for binding lysophosphatidic acid |
| 07/17/2014 | US20140199290 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof |
| 07/17/2014 | US20140199282 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/17/2014 | US20140199262 Method for manufacturing protein drug |
| 07/17/2014 | US20140199259 Stabilized liquid formulation |
| 07/17/2014 | US20140199242 Compositions and methods for detection and treatment of cancer |
| 07/17/2014 | US20140199238 Targeting of Bone Marrow Neovasculature |
| 07/17/2014 | US20140199237 Methods and compositions for modulation of olfml3 mediated angiogenesis |
| 07/16/2014 | EP2754713A1 ANTIBODY AGAINST MUTANT alpha-ACTININ-4 |
| 07/16/2014 | EP2754672A1 Antibody capable of binding to specific region of periostin, and method for measuring periostin using same |
| 07/16/2014 | EP2754671A2 Anti MIF antibodies |
| 07/16/2014 | EP2754670A1 Blood-brain barrier permeable peptide compositions |
| 07/16/2014 | EP2753937A1 Characterization of cho-mif gene and protein, and use thereof |
| 07/16/2014 | EP2753646A1 Anti-cd40 antibodies, uses and methods |
| 07/16/2014 | EP2753645A1 Caninised antibodies and method for the production of same |
| 07/16/2014 | EP2753644A1 Broadly neutralizing vhh against hiv-1 |
| 07/16/2014 | EP2753356A1 Anti-siglec-15 antibodies and uses thereof |
| 07/16/2014 | CN1638800B 抗cd30的人类单克隆抗体 The human monoclonal antibody anti-cd30 |
| 07/16/2014 | CN103930445A 双靶向 Dual Targeting |
| 07/16/2014 | CN103930444A 用前蛋白转化酶枯草溶菌素-9(PCSK9)抑制剂降低脂蛋白(a)水平的方法 With a proprotein convertase subtilisin -9 (PCSK9) inhibitors decrease lipoprotein (a) level of a |
| 07/16/2014 | CN103930443A 通过拮抗il-6受体抑制肿瘤生长的方法 Il-6 receptor by antagonizing the inhibition of tumor growth method |
| 07/16/2014 | CN103930442A 抗cd40抗体、用途和方法 Anti-cd40 antibodies, and methods of use |
| 07/16/2014 | CN103930435A 增加植物中病毒样颗粒的产率 Increase the yield of a plant virus-like particles |
| 07/16/2014 | CN103930129A 用于促进凝血的化合物 Compounds used to promote blood clotting |
| 07/16/2014 | CN103930124A 无精氨酸的tnfr：fc-融合多肽组合物及使用方法 No arginine tnfr: fc- fusion polypeptide compositions and methods of use |
| 07/16/2014 | CN103926413A 一种用尿液进行癌症快速检测的试剂条的制备方法 A preparation method for cancer using urine reagent strip for rapid detection of |
| 07/16/2014 | CN103923892A 通过在植物或其部分中提高或产生一种或更多活性具有提高产量的植物 By increasing or generating one or more of the active in a plant or a part thereof with increased yield in a plant |
| 07/16/2014 | CN103923882A 甲肝病毒单克隆抗体及其应用 Hepatitis A virus monoclonal antibodies and their application |
| 07/16/2014 | CN103923881A 甲肝病毒单克隆抗体及其应用 Hepatitis A virus monoclonal antibodies and their application |
| 07/16/2014 | CN103923214A 抗肝癌干细胞单克隆抗体及其应用 Monoclonal antibodies against hepatocellular carcinoma stem cells and its application |
| 07/16/2014 | CN103923213A 结合淋巴细胞活化基因3(lag-3)之人类抗体及其用途 Combined lymphocyte activation gene 3 (lag-3) of human antibodies and their use |
| 07/16/2014 | CN103923212A Ehd2抗体及其在制备乳腺癌免疫组化检测试剂中的应用 Ehd2 antibodies and their application in the manufacture of breast cancer immunohistochemistry reagents |
| 07/16/2014 | CN103923174A Cyr61/CCN1蛋白抗原表位多肽及其抑制剂和单抗及其应用 Cyr61 / CCN1 protein epitope peptides and their inhibitors and monoclonal antibody and its application |
| 07/16/2014 | CN103087173B 基于TGF-β1的B细胞抗原表位的合成肽疫苗及其应用 TGF-β1 on the B cell epitope of a synthetic peptide vaccine and Applications |
| 07/16/2014 | CN103060273B 分泌samhd1蛋白单克隆抗体的杂交瘤细胞株、由该细胞株分泌的单克隆抗体及应用 Monoclonal antibodies secreted samhd1 hybridoma cell lines secreting cell lines by the monoclonal antibody and application |
| 07/16/2014 | CN103012589B 人源抗人血管内皮细胞生长因子抗体及其应用 Human anti-human vascular endothelial growth factor antibody and its application |
| 07/16/2014 | CN102993300B 鸭坦布苏病毒多克隆抗体及其制备方法 Ap Tan Busu virus polyclonal antibodies and methods |
| 07/16/2014 | CN102924601B 一种莱克多巴胺单克隆抗体的制备方法 A process for producing monoclonal antibodies ractopamine |
| 07/16/2014 | CN102753577B 双特异性抗-vegf/抗-ang-2抗体 Bispecific anti -vegf / anti -ang-2 antibody |
| 07/16/2014 | CN102747041B 抗蓝藻重组抗体多肽及其基因与制备方法 Anti-cyanobacterial genes and polypeptides and recombinant antibody preparation |
| 07/16/2014 | CN102690351B 间日疟原虫醛缩酶蛋白单克隆抗体的制备方法 Preparation vivax aldolase protein monoclonal antibodies |
| 07/16/2014 | CN102553297B 微型高效克伦特罗免疫亲和层析柱制备及应用 Miniature efficient preparation and application of clenbuterol immunoaffinity column |
| 07/16/2014 | CN102414222B 抗硫苷脂和抗硫酸化蛋白聚糖抗体及其用途 Anti-sulfatide and anti-sulfated proteoglycan antibodies and their use |
| 07/16/2014 | CN102369218B 抗-FcRH5抗体和免疫缀合物以及应用方法 Antibodies and anti--FcRH5 immunoconjugates and application methods |
| 07/16/2014 | CN102325796B 抗人α9整合素抗体及其用途 Anti-human α9 integrin antibodies and their use |
| 07/16/2014 | CN102300875B 肾病相关的生物标记 Nephropathy biomarkers |
| 07/16/2014 | CN102015766B 用于对巨细胞病毒感染进行治疗以及诊断的组合物以及方法 For the treatment of cytomegalovirus infection and diagnostic compositions and methods |
| 07/16/2014 | CN101967490B 木聚糖酶、编码木聚糖酶的核酸以及制备和应用它们的方法 Xylanase, xylanase-encoding nucleic acids and methods for their preparation and application |
| 07/16/2014 | CN101903402B 抗tl1a的人源化抗体 Anti tl1a of humanized antibody |
| 07/16/2014 | CN101849001B 修饰抗体的方法和具有改善的功能性质的修饰抗体 Modified antibodies having improved functional properties of the modified antibody |
| 07/15/2014 | US8779108 Targeted binding agents against B7-H1 |
| 07/15/2014 | US8779107 Composition for targeting dendritic cells |
| 07/15/2014 | US8779106 Antibodies to human β-adrenergic receptor kinase |
| 07/15/2014 | US8779105 Monoclonal antibodies to programmed death 1 (PD-1) |
| 07/15/2014 | US8779104 EMP2 antibodies and methods of use thereof causing regression of a solid tumor or symptoms thereof |
| 07/15/2014 | US8779103 Drug fusions and conjugates |
| 07/15/2014 | US8779102 Recognition molecules for the treatment and detection of tumors |
| 07/15/2014 | US8779100 Humanized anti-beta7 antagonists and uses therefor |
| 07/15/2014 | US8779099 MIF antagonists |
| 07/15/2014 | US8779098 B7-H3L cell surface antigen and antibodies that bind thereto |
| 07/15/2014 | US8779094 Low viscosity highly concentrated suspensions |
| 07/15/2014 | US8779091 Methods for selective targeting |
| 07/15/2014 | US8778886 Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits |
| 07/15/2014 | US8778885 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
| 07/15/2014 | US8778699 Detection of degradation products of canine NT-proBNP |
| 07/15/2014 | US8778684 Herpes simplex virus complex |
| 07/15/2014 | US8778678 Composition of activated CD4 cells |
| 07/15/2014 | US8778349 Modification of intrinsically disordered sequences for the preparation of vaccines |
| 07/15/2014 | US8778346 Anti-IL-23 antibodies |
| 07/15/2014 | US8778345 Anti-CD40 antibodies |
| 07/15/2014 | US8778344 Method of treating atopic dermatitis with antibody to zcytor17 ligand |
| 07/15/2014 | US8778342 Antibody therapy |
| 07/15/2014 | US8778339 Combination of FcγRIIB-specific antibodies and CD20-specific antibodies and methods of use thereof |